CIK 0000875045 · Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330112644
- Phone
- 6176792000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-05 | ALEXANDER SUSAN H EVP Chief Legal Officer | Gift | −20,082 | 31,601 | ||
| 2024-11-05 | ALEXANDER SUSAN H EVP Chief Legal Officer | Gift | +20,082 | 20,082 | ||
| 2024-11-01 | Grogan Jane Head of Research | Option exercise | +695 | 695 | ||
| 2024-11-01 | Grogan Jane Head of Research | Shares withheld for taxes | −204 | $173.79 | $35K | 491 |
| 2024-11-01 | Grogan Jane Head of Research | Option exercise · Restricted Stock Unit | −695 | 1,390 | ||
| 2024-09-03 | Singhal Priya Head of Development | Sale 10b5-1 | −431 | $204.22 | $88K | 5,316.48 |
| 2024-08-30 | Singhal Priya Head of Development | Option exercise 10b5-1 | +1,668 | 6,554.48 | ||
| 2024-08-30 | Singhal Priya Head of Development | Shares withheld for taxes 10b5-1 | −807 | $204.76 | $165K | 5,747.48 |
| 2024-08-30 | Singhal Priya Head of Development | Option exercise · Restricted Stock Unit 10b5-1 | −1,668 | 1,669 | ||
| 2024-06-21 | SHERWIN STEPHEN A Director | Grant or award | +1,340 | 20,078 | ||
| 2024-06-21 | Mantas Jesus B Director | Grant or award | +1,340 | 7,388 | ||
| 2024-06-21 | Rowinsky Eric K Director | Grant or award | +1,340 | 21,969 | ||
| 2024-06-21 | LANGER SUSAN Director | Grant or award | +1,340 | 2,759.1 | ||
| 2024-06-21 | Patolawala Monish D Director | Grant or award | +1,340 | 1,340 | ||
| 2024-06-21 | HAWKINS WILLIAM A Director | Grant or award | +1,340 | 6,490 | ||
| 2024-06-21 | Freire Maria C Director | Grant or award | +1,340 | 4,445 | ||
| 2024-06-21 | DORSA CAROLINE Director | Grant or award | +1,785 | 26,607 | ||
| 2024-05-01 | Keeney Adam Head of Corporate Development | Option exercise | +938 | 938 | ||
| 2024-05-01 | Keeney Adam Head of Corporate Development | Shares withheld for taxes | −276 | $216.13 | $60K | 662 |
| 2024-05-01 | Keeney Adam Head of Corporate Development | Option exercise · Restricted Stock Unit | −938 | 1,877 |
Page 13 of 29 · 579 trades